Citadel Advisors Portfolio holdings
Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$9.91B |
| 2 |
SPCX
SpaceX
SPCX
|
+$871M |
| 3 |
Eli Lilly
LLY
|
+$719M |
| 4 |
Amazon
AMZN
|
+$698M |
| 5 |
Netflix
NFLX
|
+$627M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Micron Technology
MU
|
+$3B |
| 2 |
State Street SPDR Dow Jones Industrial Average ETF Trust
DIA
|
+$1.54B |
| 3 |
TSMC
TSM
|
+$1.42B |
| 4 |
NVIDIA
NVDA
|
+$1.41B |
| 5 |
SNDK
Sandisk
SNDK
|
+$771M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 82.67% |
| 2 | Technology | 3.92% |
| 3 | Healthcare | 2.55% |
| 4 | Industrials | 2.24% |
| 5 | Financials | 2.13% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
CCD
6476
Calamos Dynamic Convertible & Income Fund
CCD
$664M
| $2.01M | ﹤0.01% |
78,136
+56,895
| +268% | +$1.39M |
|
6477
PUT
Morningstar
MORN
$7.63B
| $2.01M | ﹤0.01% |
12,900
+4,200
| +48% | +$730K |
|
6478
8x8 Inc
EGHT
$264M
| $2.01M | ﹤0.01% |
1,176,821
+1,126,742
| +2,250% | +$2.27M |
|
6479
PUT
Box
BOX
$4.82B
| $2.01M | ﹤0.01% |
75,800
+47,000
| +163% | +$1.17M |
|
|
LRCU
6480
PUT
Tradr 2X Long LRCX Daily ETF
LRCU
$29.7M
| $2.01M | ﹤0.01% |
18,000
+6,600
| +58% | +$399K |
|
|
MIAX
6481
PUT
Miami International Holdings
MIAX
$3.98B
| $2.01M | ﹤0.01% |
54,100
+7,300
| +16% | +$326K |
|
|
NAGE
6482
Niagen Bioscience
NAGE
$236M
| $2.01M | ﹤0.01% |
630,109
+99,632
| +19% | +$404K |
|
|
TSSI
6483
PUT
TSS Inc
TSSI
$232M
| $2.01M | ﹤0.01% |
163,400
+82,200
| +101% | +$1.11M |
|
|
NVMI
6484
PUT
Nova
NVMI
$10.6B
| $2.01M | ﹤0.01% |
3,700
-3,900
| -51% | -$2M |
|
|
LLYX
6485
Defiance Daily Target 2x Long LLY ETF
LLYX
$46.7M
| $2.01M | ﹤0.01% |
72,419
+47,472
| +190% | +$989K |
|
6486
DXP Enterprises
DXPE
$2.8B
| $2.01M | ﹤0.01% |
11,893
+8,096
| +213% | +$1.28M |
|
6487
SIGA Technologies
SIGA
$214M
| $2.01M | ﹤0.01% |
551,246
-153,891
| -22% | -$689K |
|
6488
CALL
Diebold Nixdorf
DBD
$2.2B
| $2.01M | ﹤0.01% |
23,600
+15,000
| +174% | +$1.21M |
|
6489
Phathom Pharmaceuticals
PHAT
$676M
| $2.01M | ﹤0.01% |
184,901
-198,157
| -52% | -$2.26M |
|
6490
PUT
YieldMax Ultra Option Income Strategy ETF
ULTY
$722M
| $2.01M | ﹤0.01% |
67,820
+11,580
| +21% | +$360K |
|
6491
CALL
Envista
NVST
$4B
| $2.01M | ﹤0.01% |
+76,100
| New | +$1.92M |
|
6492
Fidelity Fundamental Large Cap Core ETF
FFLC
$1.2B
| $2M | ﹤0.01% |
+34,032
| New | +$1.95M |
|
6493
Strive Inc
ASST
$2.67B
| $2M | ﹤0.01% |
183,711
+27,069
| +17% | +$401K |
|
6494
Global X Aging Population ETF
AGNG
$90.9M
| $2M | ﹤0.01% |
55,642
+24,593
| +79% | +$870K |
|
6495
PUT
OppFi
OPFI
$613M
| $2M | ﹤0.01% |
201,700
-4,400
| -2% | -$38.1K |
|
6496
iShares Morningstar Small-Cap ETF
ISCB
$278M
| $2M | ﹤0.01% |
26,509
-4,503
| -15% | -$320K |
|
6497
Neurocrine Biosciences
NBIX
$15.4B
| $2M | ﹤0.01% |
11,863
-46,105
| -80% | -$6.84M |
|
6498
PUT
Cerence
CRNC
$374M
| $2M | ﹤0.01% |
176,600
-27,700
| -14% | -$271K |
|
6499
CALL
Reinsurance Group of America
RGA
$16.2B
| $2M | ﹤0.01% |
9,400
-1,400
| -13% | -$292K |
|
6500
PUT
ProShares Short VIX Short-Term Futures ETF
SVXY
$258M
| $2M | ﹤0.01% |
34,900
-3,100
| -8% | -$162K |
|
Similar funds
Citadel Advisors's Q2 2026 Portfolio in Review
As of Q2 2026, Citadel Advisors held 15,445 positions worth $875B, up 41% from $618B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Citadel Advisors's Q2 2026 filing shows 2,573 new, 6,088 increased, 4,803 reduced and 1,873 closed positions. Its largest new stake was SpaceX: 5,129,884 shares worth $876M. The largest sale was Micron Technology, an estimated $3B.
By sector, the portfolio is most concentrated in Miscellaneous at 83% of assets, up from 79% a quarter earlier, followed by Technology and Healthcare.
- Citadel Advisors's largest Q2 2026 buy was SpaceX: 5,129,884 shares worth $876M.
- Citadel Advisors added most to iShares Core S&P 500 ETF in Q2 2026, an estimated $9.91B increase.
- Citadel Advisors's biggest Q2 2026 reduction was Micron Technology, cutting an estimated $3B.
- Citadel Advisors fully exited iShares 7-10 Year Treasury Bond ETF in Q2 2026, selling an estimated $325M.
- Citadel Advisors's ten largest holdings make up 23% of its $875B portfolio in Q2 2026.
- Citadel Advisors opened 2,573 new positions and closed 1,873 in Q2 2026.
- Citadel Advisors's portfolio value rose 41% quarter-over-quarter to $875B.
Based on Citadel Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.